4 completed, 1 withdrawn. 5 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 4, Withdrawn 1 |
| Phase 2 | 4 | Completed 3, Withdrawn 1 |
Follow orteronel: new trials by email Literature Review of orteronel trials Research Report on orteronel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase Ib/II Study Evaluating Orteronel (Without Prednisone) Combined With Itraconazole In Men With Castration-Resistant Prostate Cancer (CRPC) Itraconazole, Orteronel - Prostate Cancer, Castration-resistant Prostate Cancer | Phase 1 / Phase 2 | Withdrawn | Emmanuel Antonarakis, MD | 2014-06-01 | 2014-07-23 | |
| A Phase 1b Study of TAK-700 in Postmenopausal Women With Hormone-receptor Positive Metastatic Breast Cancer TAK700 - Post Menopausal, Hormone Receptor Positive Breast Cancer | Phase 1 | Completed | University of Wisconsin, Madison | 8 | 2012-11-01 | 2019-11-18 |
| Study in Japan and Ex-Japan to Characterize the Pharmacokinetic and Pharmacodynamic Response to Orteronel (TAK-700) in Chemotherapy-Naive Participants With Castration-Resistant Prostate Cancer Orteronel, Orteronel Placebo, Prednisone - Prostate Cancer | Phase 1 / Phase 2 | Completed | Millennium Pharmaceuticals, Inc. | 137 | 2012-08-20 | 2018-03-20 |
| Study of TAK-700 in Combination With Docetaxel and Prednisone in Men With Metastatic Castration-Resistant Prostate Cancer TAK-700, Docetaxel, Prednisone - Prostate Cancer | Phase 1 / Phase 2 | Completed | Millennium Pharmaceuticals, Inc. | 38 | 2010-07-01 | 2019-07-30 |
| Safety Study of TAK-700 in Subjects With Prostate Cancer. TAK-700 - Prostatic Neoplasms | Phase 1 / Phase 2 | Completed | Millennium Pharmaceuticals, Inc. | 123 | 2008-04-01 | 2016-04-04 |
Prostatic Neoplasms (4) · Neoplasm Metastasis (2) · Breast Neoplasms (1)
Millennium Pharmaceuticals, Inc. (3) · Emmanuel Antonarakis, MD (1) · University of Wisconsin, Madison (1)
United States (5)